Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-08-13
2011-11-22
Chung, Susannah (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S300100, C549S079000
Reexamination Certificate
active
08063084
ABSTRACT:
The present invention provides heterocyclic derivatives that modulate the activity of stearoyl-CoA desaturase. Methods of using such derivatives to modulate the activity of stearoyl-CoA desaturase and pharmaceutical compositions comprising such derivatives are also encompassed.
REFERENCES:
patent: 3998952 (1976-12-01), Ilvespaa
patent: 4058617 (1977-11-01), Ilvespaa
patent: 2009/0156615 (2009-06-01), Dales et al.
patent: 2009/0264444 (2009-10-01), Chowdhury et al.
patent: 2010/0029718 (2010-02-01), Dales et al.
patent: 2010/0029722 (2010-02-01), Dales et al.
patent: 2348284 (1974-04-01), None
patent: 1621539 (2004-07-01), None
patent: 44282 (1979-01-01), None
patent: 9921555 (1999-05-01), None
patent: 0110865 (2001-02-01), None
patent: 0174811 (2001-10-01), None
patent: 02051442 (2002-07-01), None
patent: 02100433 (2002-12-01), None
patent: 2005077937 (2005-08-01), None
patent: 2006/034440 (2006-03-01), None
patent: 2008127349 (2008-10-01), None
patent: 2009103739 (2009-08-01), None
patent: 2009156484 (2009-12-01), None
Patini et al., Chem. Rev., 1996, vol. 96, pp. 3147-3176.
Robert, et al., “Synthesis and antileishmanial activity of new imidazolidin-2-one derivatives” European Journal of Medicinal Chemistry (2003), 38(7-8), 711-718.
Alvarez, et al., “Inhibition of Parasite Protein Kinase C by New Antileishmanial Imidazolidin-2-one Compounds” Journal of Enzyme Inhibition and Medicinal Chemistry (2002), 17(6), 443-447.
Kosary, et al., “Synthesis of thiazole derivatives with positive inotropic effect” Pharmazie (1987), 42(6), 373-5.
U.S. Appl. No. 12/438,654, filed Aug. 22, 2007 in the name of Novartis.
Dales Natalie
Fonarev Julia
Fu Jian-min
Kamboj Rajender
Kodumuru Vishnumurthy
Chung Susannah
Devlin Theresa
Novartis AG
Xenon Pharmaceuticals Inc.
LandOfFree
Heterocyclic compounds suitable for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic compounds suitable for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic compounds suitable for the treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4284149